Researchers identify amino acid that may play role for predicting, treating long COVID
Dr. Ziyad Al-Aly from the St. Louis VA Healthcare System talks about a study that found an increased risk of death in patients who developed so-called 'long COVID.' ALBERTA, Canada - Researchers at the University of Alberta have identified an amino acid that may play a key role in predicting outcomes and treating a severe post-COVID-19 condition, also known as long COVID.
In the study, published last week in Cell Reports Medicine, the team followed 117 Alberta patients, who were admitted to a hospital with COVID-19.
The patients took blood samples upon admission and at six months. The researchers found that 55% of the patients went on to develop long COVID.
Researchers analyzed the patients’ blood for changes in proteins and metabolites, as well as signs of inflammation. They then reviewed the results using machine learning and developed a predictive model composed of 20 molecules.
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|